BDBM25190 2-chloro-4-fluoro-5-({7-[3-({[2-(morpholin-4-yl)ethyl]amino}methyl)phenyl]quinolin-4-yl}amino)phenol::7-substituted 4-anilinoquinoline, 30
SMILES: Oc1cc(Nc2ccnc3cc(ccc23)-c2cccc(CNCCN3CCOCC3)c2)c(F)cc1Cl
InChI Key: InChIKey=KWEPTXFPNVUYJW-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proto-oncogene tyrosine-protein kinase receptor Ret (Homo sapiens (Human)) | BDBM25190 (2-chloro-4-fluoro-5-({7-[3-({[2-(morpholin-4-yl)et...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents | Article PubMed | n/a | n/a | 75 | n/a | n/a | n/a | n/a | 7.4 | 22 |
GlaxoSmithKline | Assay Description The biochemical activity of compound was determined by incubation with Ret kinase and the substrate in the presence of ATP/ [gamma-33P] ATP. After in... | Bioorg Med Chem Lett 17: 5886-93 (2007) Article DOI: 10.1016/j.bmcl.2007.07.104 BindingDB Entry DOI: 10.7270/Q2H1309S | |||||||||||
More data for this Ligand-Target Pair |